To help fulfill unmet medical needs, sophisticated drug delivery systems are being developed with many innovative combinations of pharmaceuticals, biologics and medical devices. While these combination products have enormous potential, they also present unique challenges in development and approval. One challenge for combination products is the development and validation of analytical methods to assess the quality, safety and stability of combination products.    Please see our technical library for a free white paper titled “Analytical Methods for Single Entity Combination Products”   This white paper will focus on the analytical methods needed for single entity combination products.